Recurrent transcriptional responses in AML and MDS patients treated with decitabine-Reference-Cited by-同舟云学术

Recurrent transcriptional responses in AML and MDS patients treated with decitabine

Published:2022-07 Issue: Volume:111 Page:50-65
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Upadhyay Pawan^ORCID,Beales Jeremy,Shah Nakul M.^ORCID,Gruszczynska Agata,Miller Christopher A.,Petti Allegra A.^ORCID,Ramakrishnan Sai Mukund,Link Daniel C.^ORCID,Ley Timothy J.,Welch John S.^ORCID

Funder

National Cancer Institute

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference49 articles.

1. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines;Hagemann;PLoS One,2011

2. Covalent bond formation between a DNA–cytosine methyltransferase and DNA containing 5-azacytosine;Santi;Proc Natl Acad Sci USA.,1984

3. Trapped in action: direct visualization of DNA methyltransferase activity in living cells;Schermelleh;Nat Methods,2005

4. Activation of the hprt gene on the inactive X chromosome in transformed diploid female Chinese hamster cells;Grant;J Cell Sci,1989

5. DNA methylation changes in hematologic malignancies: biologic and clinical implications;Issa;Leukemia,1997

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythroid Predominance in Bone Marrow Biopsies of Acute Myeloid Leukemia Patients after Decitabine Treatment Correlates with Mutation Profile and Complete Remission;Pathobiology;2024-04-20

2. Advances in single-cell RNA sequencing and its applications in cancer research;Journal of Hematology & Oncology;2023-08-24

3. Genomic landscape of TP53-mutated myeloid malignancies;Blood Advances;2023-08-11

4. In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts;Leukemia;2023-04-06

5. Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature;Frontiers in Immunology;2023-01-13